PCYN
PROCYON CORP
Key Financials
Net Income
$-341140
↓ 998.3%
Operating Income
$-231705
↓ 137.9%
EPS (Diluted)
$-0.04
↓ 300.0%
Total Liabilities
$917122.00
↓ 3.1%
Gross Profit
$3.9M
↑ 9.0%
Cash & Equivalents
$290287.00
↑ 7.4%
Revenue
$5.0M
↑ 6.4%
Shareholders' Equity
$2.3M
↑ 1.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 11/8/2024 | View on SEC |
| 8-K | 11/8/2024 | View on SEC |
| 10-K | 10/25/2024 | View on SEC |
| 4 | 10/23/2024 | View on SEC |
| 4 | 10/23/2024 | View on SEC |
| 4 | 10/23/2024 | View on SEC |
| 4 | 10/23/2024 | View on SEC |
| 8-K | 10/22/2024 | View on SEC |
| NT 10-K | 9/30/2024 | View on SEC |
| 4 | 6/27/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PCYN |
| Company Name | PROCYON CORP |
| CIK | 812306 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | CO |
| Phone | (727)447-2998 |